Filing Flows › IDEX (IEX) › Q2 2025
IDEX (IEX) Q2 2025 earnings results (second quarter 2025)
10-Q filed Jul 30, 2025
IDEX (IEX) reported revenue of $865M for the second quarter 2025 (Q2 2025), +7% from a year earlier and +6% from the quarter before. Operating margin was 21.7%, net earnings $131M (15.1% of revenue).
IDEX, Q2 2025: revenue $865M (+7% year over year), operating margin 21.7%, net earnings $131M, operating cash flow $162M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $865M | +6% | +7% |
| Gross profit | $392M | +6% | +7% |
| Operating profit | $188M | +32% | +3% |
| Net earnings | $131M | +37% | -7% |
| Operating cash flow | $162M | +53% | +21% |
| Free cash flow | $147M | — | +25% |
What changed
Revenue was $865.4M in Q2 2025, up 7% year over year and up 6% from the previous quarter. Health & Science Technologies was the largest line at 42% of revenue. Health & Science Technologies added $60.9M year over year (up 20%), 105% of the total change. Fluid & Metering Technologies declined 3%.
Gross margin was 45.3%, down 0.1 points from a year earlier. Operating profit was $187.9M, a 21.7% margin (down 0.9 points year over year). Of the extra revenue versus a year earlier, 9% reached operating profit, below the 23% margin then. Operating expenses grew 11% against revenue growth of 7%. The fastest-growing cost line was SG&A (+11%). Net earnings were $131.6M, down 7% year over year. The effective tax rate was 22.8%.
Operating cash flow was $161.7M (up 21% year over year), 123% of net earnings. Non-cash charges added back $51.0M of depreciation and amortization and $5.2M of share-based compensation. Working capital and other items used $25.6M. After capital expenditures ($14.8M), free cash flow as the company reports it was $146.9M.
Questions
What was IDEX's revenue in the second quarter 2025?
IDEX (IEX) reported revenue of $865M for the second quarter 2025 (Q2 2025), +7% from a year earlier and +6% from the quarter before.
Was IDEX profitable in the second quarter 2025?
Operating profit was $188M (21.7% of revenue) and net earnings $131M.
Source: IDEX 10-Q on SEC EDGAR.